• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

S.R. One

edit

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care.

Milestones

edit

• 
  S.R. One invested in CalciMedica. (7/31/07)
  Posted 3/19/10 at 5:18am via venturebeat.com
• 
  S.R. One invested in Rib-X Pharmaceuticals. (1/25/09)
  Posted 4/17/09 at 8:17am via rib-x.com

Investments

Videos

Sources

1. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing (rib-x.com) [edit]
2. CalciMedica raises $1.5M for inflammatory disease (venturebeat.com) [edit]